Efficacy of magnesium supplementation in the prophylaxis of migraine: a systematic review of clinical trials comparing oral magnesium to placebo or standard care
Abstract
Abstract Background Migraine remains a significant global burden, necessitating effective non-pharmacological alternatives. Magnesium plays a critical role in migraine pathophysiology through NMDA receptor blockade, neurotransmitter regulation, and the inhibition of cortical spreading depression. However, clinical data remain contradictory, particularly regarding the efficacy of various magnesium salts. Objective This systematic review evaluates the efficacy and safety of oral magnesium supplementation compared to placebo or standard care (sodium valproate) for migraine prophylaxis. Methods We analyzed randomized, double-blind trials and crossover studies involving diverse populations in Germany, Iran, Italy, and Turkey. Interventions included daily doses of 360–600 mg across multiple formulations: magnesium dicitrate, oxide, aspartate, and pyrrolidone carboxylic acid. Results Efficacy varied significantly by formulation. Trimagnesium dicitrate (600 mg/day) significantly reduced attack frequency and severity compared to placebo ( p < 0.05). Conversely, magnesium aspartate failed to demonstrate superiority over placebo, necessitating early study discontinuation. In active-comparator trials, 500 mg of magnesium oxide demonstrated efficacy similar to sodium valproate. Furthermore, concurrent magnesium and valproate therapy significantly outperformed valproate monotherapy. The most common adverse effects were gastrointestinal, including diarrhea (up to 18.6%) and soft stools.…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines
- A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
- Bioaccessibility and bioavailability of phenolic compounds
- The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
- Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
- Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.